JNJ250117C126000
- 0.00
- 0.000.00%
Johnson & Johnson Newsroom
JNJ, GSK, LLY Announce M&A Deals at JP Morgan Conference
Looking Into Johnson & Johnson's Recent Short Interest
Johnson & Johnson (JNJ) Among the Best Dividend Kings to Buy Now
S&P has placed Johnson & Johnson (JNJ.US) on negative credit watch.
The rating agency S&P has placed Johnson & Johnson (JNJ.US) on a credit watch with a negative outlook, primarily due to the company's acquisition of the mental health drug developer Intra-Cellular Therapies for nearly 15 billion USD. S&P believes that this acquisition will raise Johnson & Johnson's adjusted leverage ratio to about 1.4 times, exceeding the downgrade trigger of 1 time set by S&P's ratings. Johnson & Johnson added that it expects its adjusted leverage ratio to decline to 1.1 times by the end of 2025 and to below 1 time by the end of 2026.
Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty
S&P Places Johnson & Johnson on CreditWatch Negative
What Lies Ahead for Dow ETF in Q4 Earnings?
Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?
Trump Looms Large Over Stock Markets. Why Chips, -2-
On the first day of the JPM Medical Conference, pharmaceutical giants are announcing new strategies. Could the mergers and acquisitions in Biomedical begin in 2025?
In 2025, the Biomedical mergers and acquisitions will begin.
BofA Securities Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166
Express News | Trellus Health - Entered Deal With Johnson & Johnson Health Care Systems to Support Pilot in US to Assess Potential for Trellus Elevate Program
Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166
Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal -- Update
Intra-Cellular Therapies Stock Is Surging Monday: What's Going On?
Equities Mixed Intraday as Markets Await Bank Earnings, Inflation Data
Sector Update: Health Care
Dean Omar Branham Shirley's Partners Named to List of 500 Leading Lawyers in America
UnitedHealth, Caterpillar Share Gains Contribute To Dow's 240-Point Climb
US Equity Indexes Mixed as Magnificent-7 Stocks Decline Amid Gains in Treasury Yields